In most cancers, including BC, this downregulation is known to be due to SFN gene inactivation, generally through promoter methylation; for this reason, DNA hypermethylation in the promoter of SFN has been used as a biomarker for cancer diagnosis [28]. Here, SFN is linked to breast cancer.